VIDEO: Gut Decisions: Controlling Clostridium Difficile Infections
Date Recorded: Friday, April 26, 2013
Last day to Register 4/28/2015
Instructional Hours: 1.00
Online Evaluation
Opens: 4/26/2013 Closes: 5/10/2015
Pre-Test? Yes
Post-Test? Yes*
Pricing
Consortium Members $0.00
Non-Consortium Members $0.00
Students $0.00
Credit Fee (See specific Accreditations)
*For Videos with a post test, you must score 75% or higher and complete the online evaluation to receive credit.
Presenter(s): Cassandra Salgado MD, MS
Disclosure Statement: In accordance with the ACCME Essentials and Standards, anyone involved in planning or presenting at this educational activity is required to disclose any relevant financial relationships with commercial interests in the healthcare industry. Speakers who incorporate information about off-label or investigational use of drugs or devices are asked to disclose that information at the beginning of their presentation. Any financial disclosures will be provided at the beginning of the presentation.
Notes: This SCHOOLS presentation is a counterpart for its sister article in the latest edition of Progressnotes and will focus on making the right preventive, diagnostic and treatment choices to better control Clostridium difficile infections. LINK TO WATCH PROGRAM: http://www.scahec.net/schools/programs/2013.04.26.cdiff.html

Credit Statements
 Credit Fee (in addition to registration fee)
Physicians
$0.00
The Medical University of South Carolina designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All Other Participants
$0.00
This program provides 1 CEUs by South Carolina AHEC and meets South Carolina AHEC Best Practice Standards.

Objectives
Upon completion of this activity, participants will be able to:
Describe the increased disease severity and mortality associated with the more virulent NAP1 strain of C. difficile and list the pharmacological approaches that have been most effective in its control
Identify the antibiotics typically associated with development of C. difficile infection (CDI) and use good antibiotic stewardship in helping prevent the spread of CDI
Recognize the importance of the new polymerase chain reaction assay in identifying CDI early and implement appropriate infection control precautions promptly to minimize the spread of CDI
Describe some of the new directions in the prevention of CDI, including fecal transplants and probiotics